Key result
Incomplete Kawasaki disease progresses to diffuse giant tricoronary aneurysms despite timely IVIG and steroid therapy.
Why the study?
Giant coronary artery aneurysms occur in 0.16% to 1% of children with Kawasaki disease. In incomplete Kawasaki disease, the incidence is unclear, though the risk of coronary lesions is similar or higher.
Case Report (n=1)
No
Incomplete Kawasaki disease can rapidly progress to giant tricoronary aneurysms even when treated within 6 days with IVIG and steroids after normal initial echocardiograms, mandating close serial echocardiographic surveillance.
Answers are grounded in this paper and cite their sources.
Supports serial echocardiography in incomplete Kawasaki disease; leaves open optimal escalation beyond early IVIG.
BACKGROUND: Giant coronary artery aneurysms occur in 0.16% to 1% of children with Kawasaki disease; in incomplete disease, the incidence is unclear, but coronary lesion risk is similar or higher. CASE SUMMARY: We report a case of incomplete Kawasaki disease in a 2-year-old boy that, despite early treatment, progressed to severe coronary involvement. Initial echocardiography was normal, but repeat imaging revealed diffuse giant coronary artery aneurysms (left anterior descending artery, right coronary artery, left circumflex artery). He required multiple anti-inflammatory therapies (intravenous immunoglobulin, infliximab) and lifelong antithrombotic management with aspirin and anticoagulation. DISCUSSION: This case illustrates the challenges of diagnosing and managing incomplete Kawasaki disease, particularly when initial symptoms overlap with common viral infections and when early echocardiography is normal. Early risk stratification, guided by age and initial coronary z-scores, is critical for identifying high-risk patients who may benefit from adjunctive therapies. It demonstrates that severe coronary involvement can progress even after timely treatment and underscores the importance of close monitoring. TAKE-HOME MESSAGE: Incomplete Kawasaki disease can rapidly cause giant coronary aneurysms despite timely treatment, making serial echocardiography essential.
No takes yet. Share an insight, caveat, or question.
Benitez et al. (2026) conducted a case report in Incomplete Kawasaki disease with rapid coronary aneurysm progression (n=1). Intravenous immunoglobulin, aspirin, methylprednisolone, infliximab, and antithrombotic therapy (warfarin transitioned to enoxaparin plus clopidogrel) was evaluated on Progression and stability of giant coronary artery aneurysms. Incomplete Kawasaki disease progressed to diffuse giant tricoronary aneurysms by day 26 despite timely IVIG and steroids on day 6 and normal initial echocardiograms.
Synapse has enriched 10 related papers. Consider them for comparative context: